No black box warning on record for Inmazeb
As of the latest FDA labeling reviewed, Inmazeb (ATOLTIVIMAB, MAFTIVIMAB, AND ODESIVIMAB-EBGN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Inmazeb medicine page for the complete safety profile.